Most recently, comprehensive analyses of common genetic variation across the IGF1, IGFBP1, and IGFBP3 genes were conducted in two prospective cohorts [8], [9], [11], but no association with breast cancer risk was observed. This evidence concerns the gene IGFBP3 and breast carcinoma.